Skip to the page

Data / Medical devices / United States / Medtox Diagnostics, Inc.

Medtox Diagnostics, Inc.: FDA-registered device maker in Burlington, NC, United States, 22 510(k) clearances

Medtox Diagnostics, Inc. is registered with the FDA (registration 1050155) in Burlington, NC, United States. It lists 18 device types. The FDA files 22 510(k) clearances under its listings, the newest dated January 29, 2026. 2 recall events name it as the recalling firm. Registered through 2026. FDA data exported November 2, 2026.

SpecStream is the live web data engine for teams and agents. It reads the FDA registration and listing, 510(k), PMA, recall and enforcement files from openFDA every week, and this page is that reading, joined by the FDA's own numbers. Ask for the makers of any device type in any country and new clearances, approvals and recalls arrive in your sheet, CRM, Slack or agent as the FDA publishes them.

FDA registration number
1050155
Address
1238 Anthony Rd, Burlington, NC, United States, 27215
Owner or operator
MEDTOX DIAGNOSTICS, INC. (1050155)
Roles
Manufacturer, Manufacturer for export, Specification developer
First device listed
September 29, 2003
Registered through
2026
Brand names listed
EZ-SCREEN, Labcorp, Labcorp Comfort Draw, MEDTOX, MEDTOX OXYCODONE, MEDTOXScan, P-V MEDTOXScan, PROFILE-II and more

Devices it lists

510(k) clearances

The 510(k) numbers this establishment lists, with the FDA decision on each. The applicant is the company that holds the clearance.

Decided510(k) numberDeviceProduct codeDecisionApplicantSource
January 29, 2026K252684Labcorp Fentanyl Urine Visual TestDJGSubstantially EquivalentMedtox Diagnostics, Inc.accessdata.fda.gov
February 23, 2016K153474Detectabuse Liquid Control Urine, Detectabuse Stat-Skreen Liquid Control Urine, Detectabuse Liquid Control Urine, AU/NZ, Detectabuse Liquid Control Urine, Immunoassay Series, Detectabuse Liquid Control Urine, GC/MS and Confirm seriesDIFSubstantially EquivalentBiochemical Diagnostics, Inc.accessdata.fda.gov
October 18, 2010K100951MEDTOX BUPRENORPHINE TESTDJGSubstantially EquivalentMedtox Diagnostics, Inc.accessdata.fda.gov
April 5, 2010K100023PROFILE-V MEDTOXSCAN DRUGS OF ABUSE TEST SYSTEM AND 12 DRUGS TEST SYSTEMDJGSubstantially EquivalentMedtox Diagnostics, Inc.accessdata.fda.gov
July 24, 2009K091454PROFILE-V MEDTOXSCAN DRUGS OF ABUSE TEST SYSTEMDJGSubstantially EquivalentMedtox Diagnostics, Inc.accessdata.fda.gov
February 13, 2009K080635MEDTOXSCANDKZSubstantially EquivalentMedtox Diagnostics, Inc.accessdata.fda.gov
May 12, 2006K060351MEDTOX OXYCODONEDJGSubstantially EquivalentMedtox Diagnostics, Inc.accessdata.fda.gov
October 25, 2005K050394SURE-SCREEN AMPHETAMINE, BENZODIAZEPINE, COCAINE, METHAMPHETAMINE/MDMA, METHADONE, OPIATES, PHENCYCLIDINE & CANNABINOIDSDKZSubstantially EquivalentMedtox Diagnostics, Inc.accessdata.fda.gov
July 14, 2003K031032VERDICT II, PROFILE IIDJGSubstantially EquivalentMedtox Diagnostics, Inc.accessdata.fda.gov
July 30, 2002K022141VERDICT-IIDJCSubstantially EquivalentMedtox Diagnostics, Inc.accessdata.fda.gov
May 2, 2002K020787VERDICT-II PROPOXYPHENEJXNSubstantially EquivalentMedtox Diagnostics, Inc.accessdata.fda.gov
June 8, 2001K011545VERDICT -II TCA, VERDICT-II MTDLFGSubstantially EquivalentMedtox Diagnostics, Inc.accessdata.fda.gov
June 1, 2001K010226VERDICT -II METHAMPHETAMINEDJCSubstantially EquivalentMedtox Diagnostics, Inc.accessdata.fda.gov
April 13, 2001K010959VERDICT -II BAR; VERDICT -II BZODISSubstantially EquivalentMedtox Diagnostics, Inc.accessdata.fda.gov
April 5, 2001K010564VERDICT -II THC/COC/OPI/AMP/PCP/BAR/BZO & THC/COC/BAR/BZO; PROFILE -II 7 THC/COC/OPI/AMP/PCP/BAR/BZODKZSubstantially EquivalentMedtox Diagnostics, Inc.accessdata.fda.gov
April 5, 2001K010561VERDICT -II BAR/BZODISSubstantially EquivalentMedtox Diagnostics, Inc.accessdata.fda.gov
February 14, 2001K010138PROFILE II ERLDJSubstantially EquivalentMedtox Diagnostics, Inc.accessdata.fda.gov
January 17, 2001K002331PROFILE-ERDISSubstantially EquivalentMedtox Diagnostics, Inc.accessdata.fda.gov
December 22, 2000K003687VERDICT II THC/COC/OPI/AMP, VERDICTII THC/COC/OPI,VERDICT II THC/COC/AMP,VERDICT II THC/COC/PCP,VERDICT II THC/COCDKESubstantially EquivalentMedtox Diagnostics, Inc.accessdata.fda.gov
September 28, 2000K002776MODIFICATION TO PROFILE -IILCMSubstantially EquivalentMedtox Diagnostics, Inc.accessdata.fda.gov
December 16, 1999K992111VERDICT -II OPIATES 2000DJGSubstantially EquivalentMedtox Diagnostics, Inc.accessdata.fda.gov
July 29, 1998K982211PROFILE-II MODEL 600582DKESubstantially EquivalentMedtox Diagnostics, Inc.accessdata.fda.gov

Recalls

Recall events where this establishment is the recalling firm, matched on its FEI.

InitiatedEventClassStatusProductReasonSource
April 5, 201364800Class IITerminatedPROFILE-V MEDTOXScan Drugs of Abuse Test System. For the rapid, qualitative detection of drugs of abuse in human urineReview of validation information and customer complaints which indicated preliminary screen positive results for cocaine that were not positive on confirmatory testing.accessdata.fda.gov
February 8, 200847501Not yet classifiedTerminatedMEDTOXscan ReaderReader was marketed without a 510(k).accessdata.fda.gov

Compare with other makers

Updated January 29, 2026. Read from openFDA bulk downloads (device registration and listing, 510(k), PMA, recall and enforcement files). CC0 1.0, public domain (openFDA terms of service). The files are joined on FDA identifiers: the 510(k) and PMA numbers a registration lists, and the recalling firm's FEI for recalls. Recall class comes from the FDA enforcement report. The FDA states that openFDA data is unvalidated and is not for decisions about medical care. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.